Corporate News     09-Nov-23
Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
To fund acquisition of Biocon Biologics's Nephrology and Dermatology biz in India
Eris Lifesciences has availed a Term Loan Facility from Citi Bank N.A. amounting to Rs. 280 crore for financing the acquisition of the Nephrology and Dermatology businesses pertaining to the Indian Territory of Biocon Biologics as informed by the Company on 08 November 2023.
Previous News
  Biocon to conduct board meeting
 ( Corporate News - 18-Jul-24   10:37 )
  Volumes spurt at Godfrey Phillips India Ltd counter
 ( Hot Pursuit - 15-Jul-24   14:30 )
  Biocon Ltd eases for fifth straight session
 ( Hot Pursuit - 12-Jul-24   13:36 )
  Eris Lifesciences allots 22,492 equity shares under ESOP
 ( Corporate News - 24-Jun-24   12:26 )
  Nifty below 23,450 mark; media shares under pressure
 ( Market Commentary - Mid-Session 24-Jun-24   10:33 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
 ( Corporate News - 24-Jun-24   09:01 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon Ltd soars 2.25%, up for fifth straight session
 ( Hot Pursuit - 11-Jun-24   13:00 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
Other Stories
  Intelligent Supply Chain Infrastru.Trust to declare Quarterly Result
  23-Jul-24   20:10
  Suzlon Energy schedules AGM
  23-Jul-24   20:10
  Lotus Eye Hospital & Institute to convene AGM
  23-Jul-24   20:10
  Sharanam Infraproject & Trading schedules AGM
  23-Jul-24   20:10
  Capri Global Capital receives credit rating for CP programme
  23-Jul-24   19:34
  Infosys partners with UVC Partners
  23-Jul-24   19:10
  Himadri Speciality Chemical allots CPs aggregating Rs 50 cr
  23-Jul-24   19:09
  Outcome of Oil & Natural Gas Corpn regarding sustainable capital restructuring of OPaL
  23-Jul-24   19:05
  MCX announces resignation of director
  23-Jul-24   19:04
  Board of SpiceJet approves QIP issue of Rs 3,000 cr
  23-Jul-24   18:56
Back Top